Novo Nordisk shares jump 5% on promising weight loss trial results; Eli Lilly dips
Novo Nordisk shares climbed 5% on Thursday morning after the Danish pharmaceutical giant reported positive early trial data for a new weight loss drug.
Source link
/cloudfront-us-east-2.images.arcpublishing.com/reuters/MMYV4NPJANOFHOMR3NHIVHWCAU.jpg "France, Germany say Russia’s publication of notes breaks diplomatic rules")
